The dose escalation phase alone takes 16 to 20 weeks for most GLP-1 medications, and meaningful weight loss really begins at therapeutic doses
Curr Med Chem 12(10):11611208
Individuals prone to being deficient in L-carnitine or for whom supplementation would be advisable, include those on dialysis or who are HIV-positive
Range of Total Body Weight Loss, Fat Free Mass Loss and Skeletal Muscle Mass Loss by Weight Loss Method
Based on the STEP 1 clinical study, the semaglutide-treated group reported weight loss beginning with the first assessment after randomization at week 4, reaching its lowest reported weight loss at week 60.[2,4] STEP 1 included 1961 patients randomly assigned to treatment with semaglutide or placebo combined with diet and exercise.[4] Dosage Forms And Strengths Semaglutide is currently available as a clear and colorless injectable solution.[2] The injections come in five different pre-filled, disposable, and single-dose pens[2]: 0.25 mg/0.5 mL 0.5 mg/0.5 mL 1 mg/0.5 mL 1.7 mg/0.5 mL 2.4 mg/0.5 mL Safety Common side effects of semaglutide are gastrointestinal-related.[2,5] These are nausea, vomiting, and diarrhea
Additionally, Wegovy's mechanism of slowing gastric emptying could theoretically affect the absorption rate of oral medications, though this is generally not clinically significant for alprazolam based on available data